Going in to 2016, it's hard not to characterize the US regulatory and policy environment as positive for the medical device industry.
There is a consensus that the FDA premarket review process in 2015 has become, on average, more efficient and more...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?